News zum Sektor Gesundheit aus Asien

 

Following a decade of exploration from the 2014 NVIDIA GTC to the PreciousGPT model series, Insilico Medicine presents the industry's first multi-agent Virtual Aging Cell (VAC) platform with biological age as a core condition. CAMBRIDGE, Mass., Aug. 14, 2026 /PRNewswire/ -- Insilico......

UBS released a research report initiating coverage on DUALITYBIO-B (09606.HK) with a Buy rating and a target price of HKD320, based on a risk-adjusted discounted cash flow (DCF) valuation. The target price corresponds to 1.2x risk-adjusted peak sales multiple. The broker believes the company's current valuation is undervalued, w......

Tokorozawa, Saitama Pref., Aug. 14 (Jiji Press)--Japanese manga artist Kazuyoshi Takeda, author of a series that depicts a World War II battle on the western Pacific island of Peleliu, emphasized the importance of learning about war so as not to repeat past mistakes. "For generations that have never experienced war, the first important step is to learn about it," the 50-year-old author of "......

Baidu AI Day open event was held today (14th). Baidu Wenku Wangpan's general AI agent GenFlow officially announced its Chinese name as "Kuku AI", while simultaneously launching standalone versions of "Kuku AI", including the Kuku AI Office PC client, Kuku AI web version, mini program and Kuku AI Enterpris......

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

MeiraGTx (MGTX) delivered earnings and revenue surprises of +538.46% and +20,637.68%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?...

Portable Device is Designed to Support a Variety of Clinical Needs WESTBOROUGH, Mass., Aug. 13, 2026 /PRNewswire/ -- Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, today announced an exclusive global distribution agreement with......

Zoci advances toward global registrational trials as net product revenue rises 11%....

Angelaligner wird gegen das Urteil eines chinesischen Gerichts bezüglich der Lösung zur Extraktion von Prämolaren Berufung einlegen; dies hat keine Auswirkungen auf die Kunden...

Wave Life Sciences has lost nearly 70% of its value this year, yet its RNA platform spans obesity, rare liver disease, and genetic disorders in ways that could make it irresistible to the right buyer. The question is which pharma giant moves first....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

The decision marks the third NMPA-approved indication for an ivonescimab-containing regimen in the country since the molecule first received authorisation in May 2024. Ivonescimab is described as an The post Akeso secures China NMPA authorisation for ivonescimab combo appeared first on Pharmaceutical Business review....

MODERN DENTAL (03600.HK) issued a positive profit alert, expecting revenue for 1H26 to range between HKD1.975 billion and HKD2.075 billion, representing a YoY increase of approximately 7.6% to 13.1%. The revenue growth was mainly driven by the group's continued organic growth, with particularly strong performance in Europe and A......

FOSUN PHARMA (02196.HK) announced that its subsidiary has initiated a Phase II clinical trial in China for FXS7553 for the treatment of chronic obstructive pulmonary disease.FXS7553 is a self-developed small-molecule oral DPP-1 inhibitor of the group, intended for the treatment of non-cystic fibrosis bronchiectasis, chronic obst......

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

At midday close, HSI rose 17 pts or 0.1% to 25,457. HSTI rose 14 pts or 0.3% to 4,790. HSCEI fell 3 pts or 0.0% to 8,443.Active Heavyweights:TENCENT (00700.HK) closed at $444, down 3.8%XIAOMI (01810.HK) closed at $26.18, down 0.7%BABA (09988.HK) closed at $123.4, up 0.7%HSI & HSCEI Constituents on Move:TINGYI (00322.HK) closed a......

SHANGHAI, Aug. 13, 2026 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") http://www.angelaligner.com said today that it will appeal the August 10 first-instance judgment by the Jinan Intermediate People's Court (Jinan City, China) that directed Angel's Chinese subsidiaries......

Angelaligner Will Appeal Chinese Court Decision about Premolar Extraction Solution, Which Has No Impact on Customers...

SHENZHEN, China, Aug. 12, 2026 /PRNewswire/ -- XtalPi Holdings Limited ("XtalPi", or the "Company") (HKEX: 2228), an innovative research platform company powered by artificial intelligence (AI) and robotics, announced that it will report its interim results for the six months ended June......

AKESO (09926.HK) announced that the new drug application for its internally developed first-in-class bispecific antibody YidafangR (Ivonescimab, PD-1/VEGF), in combination with chemotherapy for first-line treatment of advanced squamous non-small cell lung cancer, has been approved by China's National Medical Products Administrat......